[Antineoplastic agent bleomycin in malignancies of the otorhinolaryngologic region].
D000368:Aged; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001761:Bleomycin / Q000009:adverse effects / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004428:Ear Neoplasms / Q000188:drug therapy*; D004938:Esophageal Neoplasms / Q000188:drug therapy*; D005069:Evaluation Studies as Topic; D006801:Humans; D007822:Laryngeal Neoplasms / Q000188:drug therapy*; D008339:Mandibular Neoplasms / Q000188:drug therapy*; D008875:Middle Aged; D010610:Pharyngeal Neoplasms / Q000188:drug therapy*; D011658:Pulmonary Fibrosis / Q000139:chemically induced
D000903:Antibiotics, Antineoplastic; D001761:Bleomycin
Das Zytostatikum Bleomyzin bei malignen Tumoren im otorhinolaryngologischen Bereich.